The Italian Competition Authority Fines a Pharmaceutical Company for Having "Artificially Differentiated" Their Medicinal Products in Breach of Article 101 TFEU (Roche- Novartis/Farmaci Avastin e Lucentis)

Lembo, SaraThe Italian Competition Authority Fines a Pharmaceutical Company for Having "Artificially Differentiated" Their Medicinal Products in Breach of Article 101 TFEU (Roche- Novartis/Farmaci Avastin e Lucentis) Bulletin e-Competitions 2014 (gemeinsam mit Giulio Matarazzi).